Perspective Therapeutics (CATX) Change in Interest Receivables (2024 - 2026)
Perspective Therapeutics' Change in Interest Receivables history spans 3 years, with the latest figure at $392000.0 for Q1 2026.
- On a quarterly basis, Change in Interest Receivables rose 429.73% to $392000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $460000.0, a 51.78% decrease, with the full-year FY2025 number at $142000.0, down 83.86% from a year prior.
- Change in Interest Receivables hit $392000.0 in Q1 2026 for Perspective Therapeutics, up from -$163000.0 in the prior quarter.
- Over the last five years, Change in Interest Receivables for CATX hit a ceiling of $880000.0 in Q4 2024 and a floor of -$163000.0 in Q4 2025.
- Historically, Change in Interest Receivables has averaged $235666.7 across 3 years, with a median of $143000.0 in 2025.
- Biggest five-year swings in Change in Interest Receivables: tumbled 118.52% in 2025 and later surged 429.73% in 2026.
- Tracing CATX's Change in Interest Receivables over 3 years: stood at $880000.0 in 2024, then tumbled by 118.52% to -$163000.0 in 2025, then surged by 340.49% to $392000.0 in 2026.
- Business Quant data shows Change in Interest Receivables for CATX at $392000.0 in Q1 2026, -$163000.0 in Q4 2025, and $19000.0 in Q3 2025.